Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.6%
5Y CAGR+20.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+9.6%/yr
vs +15.5%/yr prior
5Y CAGR
+20.1%/yr
Recent deceleration
Acceleration
-6.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.79M | +30.8% |
| 2024 | $12.08M | -9.4% |
| 2023 | $13.33M | +11.1% |
| 2022 | $12.00M | +48.6% |
| 2021 | $8.08M | +28.0% |
| 2020 | $6.31M | +23.6% |
| 2019 | $5.10M | -24.2% |
| 2018 | $6.73M | -26.5% |
| 2017 | $9.15M | -1.2% |
| 2016 | $9.27M | - |